Wrong. Don’t worry about management, they are cashing in on this scam. Their shell finance company is financing the debt to their advantage, I’m sure of it.
And dilution is never good for the investors. The only way this shoots up is if MMs make a move when the sector goes up or management starts another Facebook campaign like they did in March. Look how that turned out.
If we get another run, get what you can and sell. Drop Falling Biosciences like a bad habit.
News 
Market Data 
Discover 
AI
